Science (New York, N.Y.) · 2026
Severe obesity in human HFpEF alters contractile protein function and organization.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jani Vivek P, Rhodehamel Marcus, Fenwick Axel J, Ma Weikang, Fisher Eli, Giannakopoulos Maria T, Moon Sun, Castillo Romi L, Kennedy Leslie M, Irving Thomas C, Tardiff Jil C, Murphy Elizabeth, Chaerkady Raghothama, Wang Qing, Barry Meaghan E, Hahn Virginia S, Sharma Kavita, Margulies Kenneth B, Bedi Kenneth C, Cammarato Anthony, Kass David A
Аннотация
Heart failure with preserved ejection fraction (HFpEF) causes substantial morbidity and mortality and has few effective therapies. Its phenotype has changed over time, with morbid obesity and metabolic defects supplanting hypertension and cardiac hypertrophy. We reveal that cardiomyocytes from patients with severe obesity and HFpEF have very depressed contractile reserve, including reduced calcium- and length-stimulated tension, power, and myosin activation compared with less-obese HFpEF and nonfailing (NF) controls with or without obesity but similar to those with advanced HF and reduced ejection fraction. Myocyte defects correlate with body mass index and exercise hemodynamics in patients with HFpEF but not NF and appear reversible upon weight loss. Increased troponin I phosphorylation at threonine 181 occurs only in heart failure with obesity, contributing to sarcomere dysfunction. Weight reduction and sarcomere enhancers may offer benefits in HFpEF with obesity.